$306 Million is the total value of Foresite Capital Management III, LLC's 26 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TOCA | New | Tocagen, Inc. | $9,059,000 | – | 753,000 | +100.0% | 2.96% | – |
| VRNA | New | Verona Pharma Plcsponsored ads | $7,152,000 | – | 613,601 | +100.0% | 2.34% | – |
| PACB | New | Pacific Biosciences of California, Inc. | $4,450,000 | – | 1,250,000 | +100.0% | 1.45% | – |
| ARGX | New | argenx SEsponsored adr | $3,744,000 | – | 176,500 | +100.0% | 1.22% | – |
| SGMO | New | Sangamo Therapeutics Inc. | $1,355,000 | – | 154,000 | +100.0% | 0.44% | – |
| INFI | New | Infinity Pharmaceuticals, Inc. | $1,160,000 | – | 738,896 | +100.0% | 0.38% | – |
| BHVN | New | Biohaven Pharmaceutical Holding Company Ltd. | $750,000 | – | 30,000 | +100.0% | 0.24% | – |
| ARDX | New | Ardelyx, Inc. | $191,000 | – | 37,500 | +100.0% | 0.06% | – |
| ABEO | New | Abeona Therapeutics, Inc. | $117,000 | – | 18,334 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Epizyme, Inc. | 24 | Q3 2021 | 17.6% |
| Acceleron Pharma Inc. | 22 | Q3 2021 | 25.9% |
| CymaBay Therapeutics, Inc. | 20 | Q3 2022 | 17.6% |
| Aerie Pharmaceuticals, Inc. | 18 | Q1 2020 | 33.5% |
| Ascendis Pharma A/S | 17 | Q3 2022 | 47.8% |
| Alder BioPharmaceuticals, Inc. | 16 | Q3 2019 | 27.4% |
| Natera, Inc. | 16 | Q3 2022 | 21.5% |
| Aimmune Therapeutics, Inc. | 16 | Q3 2019 | 8.1% |
| Verona Pharma PLC. | 15 | Q3 2022 | 30.0% |
| WAVE Life Sciences Ltd. | 15 | Q2 2019 | 20.0% |
View Foresite Capital Management III, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 4 | 2021-11-03 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 3 | 2021-02-10 |
View Foresite Capital Management III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.